Sokbom Kang

20PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsFeminist and queer theoryReproduction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 23, 2026
Consecutive Negative Screening Tests for Ovarian Cancer: A Reliable Basis for Reassurance of Low Ovarian Cancer Mortality Risk?

|Jul 25, 2026
Changes in the extensiveness of initial debulking surgery with increasing neoadjuvant chemotherapy use in advanced ovarian cancer: a nationwide population-based study.

|Mar 23, 2026
Volume over location: prioritizing case volume over regional distribution in ovarian cancer treatment.

Byeong-Chan Oh, Sokbom Kang

|Mar 03, 2026
Treatment patterns and survival outcomes according to histologic subtype in malignant ovarian germ cell tumors: a nationwide real-world cohort study.

Jaekyung Bae, Byeong-Chan Oh, Uisuk Kim

|Jan 28, 2026
Nationwide Survival Impact of Bevacizumab Under National Reimbursement for Advanced Cervical Cancer in South Korea.

Junhwan Kim, Jieun Jang, Krishnansu S Tewari

|Jan 23, 2026
Prognostic value and adjuvant treatment outcomes for the use of the JGOG prognostic model in early-stage intermediate-risk cervical cancer: a Korean Gynecologic Oncology Group study (KGOG 1028).

Uisuk Kim, Jaekyung Bae, E Sun Paik

Pageof 4

Frequent Collaborators

8 joint publications

Myong Cheol Lim

7 joint publications

Sang-Yoon Park

5 joint publications

Sang-Soo Seo

4 joint publications

Byeong-Chan Oh